文献速递性腺与生殖内分泌糖尿病肥胖与代谢综合征

遗传预测睾酮水平升高与男性冠心病风险增加相关:孟德尔随机化与生存分析

Higher Circulating Testosterone Linked to Higher CAD Risk in Men: Mendelian Randomization and Survival Analyses.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究采用孟德尔随机化方法评估循环睾酮升高对冠心病的因果效应,并观察了40-69岁男性中实测睾酮与冠心病的表型关联。结果发现遗传预测睾酮升高显著增加男性冠心病风险(OR 1.17),女性无此效应,且该关联可能由血压升高介导;观察性分析方向相反,可能受2型糖尿病和BMI混杂。

要点

  • 遗传预测睾酮升高增加男性冠心病风险(OR 1.17),女性无效应。
  • 该遗传关联在男性中可能由血压升高介导。
  • 观察性分析中实测睾酮与冠心病呈反向关联,可能受2型糖尿病和BMI混杂。

核心结论

  • 遗传预测循环睾酮升高可能增加男性冠心病风险,睾酮补充的心血管安全性应成为未来临床试验的关注点。

研究设计与样本

  • 同时在40-69岁男性队列中测试实测循环睾酮与冠心病的表型关联。

主要发现

  • 遗传预测睾酮升高与男性冠心病风险增加相关(OR 1.17,95% CI 1.07-1.27,P=3.32×10⁻⁴)。
  • 男性中的遗传关联似乎由血压升高介导。
  • 纵向观察分析中,男性实测睾酮与冠心病呈方向相反的关联,可能由2型糖尿病和BMI混杂所致。

临床怎么用

  • 临床考虑睾酮补充治疗时,应关注男性患者的心血管风险,尤其是血压变化。
  • 观察性研究中睾酮与冠心病的反向关联可能受代谢混杂影响,解读时需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Testosterone supplementation is increasingly widespread and has well-established beneficial effects on sexual function and metabolic health. However, there remains uncertainty regarding associated cardiovascular risks. OBJECTIVE: Human genetics studies demonstrated that Mendelian randomization approaches recapitulate the beneficial effects of testosterone therapy; here we apply this to cardiovascular disease. DESIGN: We performed a Mendelian randomization study to assess the causal effect of higher circulating testosterone on coronary artery disease (CAD). We also tested the phenotypic association between measured circulating testosterone and CAD in the cohort of men aged 40 to 69. PATIENTS OR OTHER PARTICIPANTS: Testosterone genetic instrument data were derived from 425 097 European ancestry adults from the UK Biobank study and CAD from single nucleotide polymorphism-level summary statistics from 1 165 690 individuals in CARDIoGRAMplusC4D. MAIN OUTCOME MEASURE(S): CAD as defined in CARDIoGRAMplusC4D was the main outcome. In longitudinal analyses, CAD was defined according to medical records and self-report. RESULTS: We found that higher genetically predicted circulating testosterone conferred a higher risk of CAD in men [odds ratio (OR): 1.17, 95% confidence interval (CI) 1.07-1.27, P = 3.32 × 10-4]. There was no evidence of an effect in women (OR: 1.01, 95% CI 0.94-1.10, P = .73). The genetic association in men appeared to be mediated by higher blood pressure. In longitudinal observational analyses, a directionally opposite association was observed in men, likely arising due to confounding by type 2 diabetes and body mass index. CONCLUSION: These data suggest that increased testosterone may increase the risk of cardiovascular disease and that this safety concern should be a focus in future clinical trials for testosterone supplementation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Morbey EJ, Day FR, Butterworth AS, et al. Higher Circulating Testosterone Linked to Higher CAD Risk in Men: Mendelian Randomization and Survival Analyses. J Clin Endocrinol Metab. 2026. PMID: 41131989. doi:10.1210/clinem/dgaf582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。